GAO report: FDA not inspecting dietary supplements from China.

The Kansas City Star (11/7, Everly) noted, "Dietary supplements and prescription drugs are pouring in from China, but US regulators are not ensuring their quality, safety or proper labeling." In fact, "federal regulators have inspected only a fraction of the hundreds of Chinese factories making prescription drugs for the US market, a new report from the Government Accountability Office says," and as a result, "consumers can't tell where imported drugs and dietary supplements are made because country-of-origin labeling laws are not being enforced." In response to the GAO report, the FDA said, "The sheer number of foreign facilities, the complexity of the drug supply chain and the rapidly changing use of suppliers all pose formidable obstacles."